Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemiaPhilipp B. Staber, Claire Dearden, Marco Herling et al.|Blood|2019Cited by 161
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 studyFatemeh Saberi Hosnijeh, Mark‐David Levin, Jeanette K. Doorduijn et al.|Experimental Hematology|2020Cited by 8
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working groupDoreen G. Te Raa, Lina van der Straten, Michel van Gelder et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 4
Quality of Life in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Improves after Minimal Residual Disease-Guided Treatment with Ibrutinib Plus VenetoclaxLaura Eurelings, Mark‐David Levin, Emelie Curovic Rotbain et al.|Blood|2024Cited by 1